Company Update
Company Update
Company Update

Valink presents at Curious2024 Ignite Session

May 18, 2021

Oxford University Innovation and LiliumX have completed the technology transfer process, establishing LiliumX as a University of Oxford spin-out. LiliumX is spun out from the Department of Biochemistry, and it is the first company in 24 years to be formed solely from this Department. As part of the spin-out process, LiliumX is licensing world-class protein conjugation technologies from Oxford University Innovation, including the SpyTag/SpyCatcher system. LiliumX is proud to be a part of the University's high-profile portfolio, and LiliumX's founders thank the Department of Biochemistry and Oxford University Innovation for their support and fruitful collaboration. Oxford University Innovation's spin-out portfolio can be found here.

Contact us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
United States

Valink Therapeutics Inc
One Broadway,
Cambridge,
Massachusetts,
02142

United Kingdom

Valink Therapeutics Ltd
Imperial I-Hub,

84 Wood Lane,

London,

W12 0BZ